A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 16, Pages 9082-9093
Publisher
Proceedings of the National Academy of Sciences
Online
2020-04-07
DOI
10.1073/pnas.2000208117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2019) Roberta Brambilla ACTA NEUROPATHOLOGICA
- Promoting remyelination in multiple sclerosis
- (2019) Nick Cunniffe et al. JOURNAL OF NEUROLOGY
- Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1
- (2018) Eugene Y. Kim et al. FASEB JOURNAL
- Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
- (2018) Wei Cai et al. PROGRESS IN NEUROBIOLOGY
- Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination
- (2018) Zita Hubler et al. NATURE
- Treatment of multiple sclerosis — success from bench to bedside
- (2018) Mar Tintore et al. Nature Reviews Neurology
- Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis
- (2018) Fucheng Luo et al. Nature Communications
- Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016)
- (2017) Hidayat Hussain et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Achievements and obstacles of remyelinating therapies in multiple sclerosis
- (2017) Martin Stangel et al. Nature Reviews Neurology
- Ursolic acid (UA): A metabolite with promising therapeutic potential
- (2016) Dharambir Kashyap et al. LIFE SCIENCES
- Regenerative Medicines for Remyelination: From Aspiration to Reality
- (2015) Robin J.M. Franklin Cell Stem Cell
- Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways
- (2015) Hua Xu et al. JOURNAL OF NEUROIMMUNOLOGY
- Ursolic Acid—A Pentacyclic Triterpenoid with a Wide Spectrum of Pharmacological Activities
- (2015) Łukasz Woźniak et al. MOLECULES
- Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
- (2015) Fadi J. Najm et al. NATURE
- A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors
- (2015) Zhengzi Qian et al. Biomed Research International
- Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
- (2014) Feng Mei et al. NATURE MEDICINE
- Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
- (2014) Jelle Praet et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- Regulation of Cyclic AMP Response Element Binding and Hippocampal Plasticity-Related Genes by Peroxisome Proliferator-Activated Receptor α
- (2013) Avik Roy et al. Cell Reports
- Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma
- (2012) Seung-Hyung Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors
- (2012) Xian-Huo Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Bioavailability, Distribution, and Antioxidative Effects of Selected Triterpenes in Mice
- (2012) Mei-Chin Yin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- S-Nitrosoglutathione Induces Ciliary Neurotrophic Factor Expression in Astrocytes, Which Has Implications to Protect the Central Nervous System under Pathological Conditions
- (2012) Manjeet K. Paintlia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CNS-specific Therapy for Ongoing EAE by Silencing IL-17 Pathway in Astrocytes
- (2012) Yaping Yan et al. MOLECULAR THERAPY
- Glial Progenitor Cell-Based Treatment and Modeling of Neurological Disease
- (2012) S. A. Goldman et al. SCIENCE
- Regulation of remyelination in multiple sclerosis
- (2011) Khalid A. Hanafy et al. FEBS LETTERS
- In vitro modeling of central nervous system myelination and remyelination
- (2011) Andrew A. Jarjour et al. GLIA
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A High Content Drug Screen Identifies Ursolic Acid as an Inhibitor of Amyloid β Protein Interactions with Its Receptor CD36
- (2011) Kim Wilkinson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ursolic Acid Induces Allograft Inflammatory Factor-1 Expression via a Nitric Oxide-Related Mechanism and Increases Neovascularization
- (2010) Ai-Wei Lee et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Retinoid X receptor gamma signaling accelerates CNS remyelination
- (2010) Jeffrey K Huang et al. NATURE NEUROSCIENCE
- Peroxisome Proliferator-Activated Receptor-γ Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells
- (2009) Antonietta Bernardo et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started